RIDGELINE BUILDS COMPANIES

Ridgeline is a Versant Ventures Discovery Engine. Founded in 2017, Ridgeline has the mission to build new leading biotech companies, operate them, help them to grow and establish their own independent footprint. Three companies, Black Diamond Therapeutics, Monte Rosa Therapeutics and Bright Peak Therapeutics are already independent. Several newly founded companies, including Matterhorn Biosciences and Cimeio Therapeutics, are operating in collaboration with Ridgeline.